Cargando…

Secreted indicators of androgen receptor activity in breast cancer pre-clinical models

PURPOSE: Accumulating evidence has attracted attention to the androgen receptor (AR) as a biomarker and therapeutic target in breast cancer. We hypothesized that AR activity within the tumor has clinical implications and investigated whether androgen responsive serum factors might serve as a minimal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanamura, Toru, Christenson, Jessica L., O’Neill, Kathleen I., Rosas, Emmanuel, Spoelstra, Nicole S., Williams, Michelle M., Richer, Jennifer K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567567/ https://www.ncbi.nlm.nih.gov/pubmed/34736512 http://dx.doi.org/10.1186/s13058-021-01478-9

Ejemplares similares

OR30-5 Androgen-Regulated Secreted Factors Promote Tumorigenesis and Immune Suppression in Breast Cancer
por: Richer, Jennifer, et al.
Publicado: (2022)

MicroRNA-200c restoration reveals a cytokine profile to enhance M1 macrophage polarization in breast cancer
por: Williams, Michelle M., et al.
Publicado: (2021)

RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast Cancer
por: Fernández, Natalia B., et al.
Publicado: (2023)

Reversing an Oncogenic Epithelial-to-Mesenchymal Transition Program in Breast Cancer Reveals Actionable Immune Suppressive Pathways
por: Williams, Michelle M., et al.
Publicado: (2021)

NPC1 Confers Metabolic Flexibility in Triple Negative Breast Cancer
por: O’Neill, Kathleen I., et al.
Publicado: (2022)

Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide
por: Cochrane, Dawn R, et al.
Publicado: (2014)

Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers
por: Cochrane, Dawn R., et al.
Publicado: (2010)

Predicting puberty in partial androgen insensitivity syndrome: Use of clinical and functional androgen receptor indices
por: Lek, Ngee, et al.
Publicado: (2018)

A Case of TSH-Secreting Pituitary Adenoma With Unusual Positive Staining for SF1
por: Robinson, Kathleen, et al.
Publicado: (2021)

Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer
por: He, Licai, et al.
Publicado: (2017)

Variable Expression of PIK3R3 and PTEN in Ewing Sarcoma Impacts Oncogenic Phenotypes
por: Niemeyer, Brian F., et al.
Publicado: (2015)

Changing pattern of gonadotropins in a patient with an adrenal‐androgen secreting tumor
por: Marcondes, José Antonio Miguel, et al.
Publicado: (2011)

Androgen regulation of the androgen receptor coregulators
por: Urbanucci, Alfonso, et al.
Publicado: (2008)

Conazole fungicides inhibit Leydig cell testosterone secretion and androgen receptor activation in vitro
por: Roelofs, Maarke J.E., et al.
Publicado: (2014)

Prostate Cancer Characteristics Associated with Response to Pre-Receptor Targeting of the Androgen Axis
por: Mostaghel, Elahe A., et al.
Publicado: (2014)

Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer
por: Denmeade, Samuel R, et al.
Publicado: (2023)

Androgen Secreting Adenoma Co- Secreting Cortisol First Diagnosed During Pregnancy
por: Al Ghareeb, Zahra, et al.
Publicado: (2021)

Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC
por: Sena, Laura A., et al.
Publicado: (2022)

Androgens and Androgen Receptor Actions on Bone Health and Disease: From Androgen Deficiency to Androgen Therapy
por: Chen, Jia-Feng, et al.
Publicado: (2019)

Androgen Receptor Drives Cellular Senescence
por: Mirochnik, Yelena, et al.
Publicado: (2012)

Massive ovarian edema masquerading as an androgen-secreting tumor
por: Ayoola-Adeola, Martins, et al.
Publicado: (2021)

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors
por: Cittelly, Diana M, et al.
Publicado: (2010)

Mutual exclusivity of ESR1 and TP53 mutations in endocrine resistant metastatic breast cancer
por: Li, Zheqi, et al.
Publicado: (2022)

Dual effects of constitutively active androgen receptor and full-length androgen receptor for N-cadherin regulation in prostate cancer
por: Cottard, Félicie, et al.
Publicado: (2017)

Androgen receptor-mediated upregulation of quaking affects androgen receptor-related prostate cancer development and anti-androgen receptor therapy
por: Zhang, Keke, et al.
Publicado: (2018)

Selective androgen receptor modulators: the future of androgen therapy?
por: Christiansen, Andrew R., et al.
Publicado: (2020)

The Role of Androgens and Androgen Receptor in Human Bladder Cancer
por: Martínez-Rojo, Elizabeth, et al.
Publicado: (2021)

Nutlin-3 inhibits androgen receptor-driven c-FLIP expression, resulting in apoptosis of prostate cancer cells
por: Logan, Ian R., et al.
Publicado: (2016)

The Androgen Hormone-Induced Increase in Androgen Receptor Protein Expression Is Caused by the Autoinduction of the Androgen Receptor Translational Activity
por: Siciliano, Tiziana, et al.
Publicado: (2022)

Androgen receptor epigenetics
por: Cai, Changmeng, et al.
Publicado: (2013)

Secreted Frizzled-related protein-1 is a negative regulator of androgen receptor activity in prostate cancer
por: Kawano, Y, et al.
Publicado: (2009)

Determining direct binders of the Androgen Receptor using a high-throughput Cellular Thermal Shift Assay
por: Shaw, Joseph, et al.
Publicado: (2018)

The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover
por: Coffey, Kelly, et al.
Publicado: (2013)

Learning Linux binary analysis: uncover the secrets of Linux binary analysis with this handy guide
por: O'Neill, Ryan
Publicado: (2016)

Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes
por: Olsen, Jan Roger, et al.
Publicado: (2016)

Plasma Androgen Receptor in Prostate Cancer
por: Conteduca, Vincenza, et al.
Publicado: (2019)

A Systematic Comparison of Antiandrogens Identifies Androgen Receptor Protein Stability as an Indicator for Treatment Response
por: Siciliano, Tiziana, et al.
Publicado: (2021)

Pure Androgen-Secreting Adrenal Adenoma Associated with Resistant Hypertension
por: Rodríguez-Gutiérrez, René, et al.
Publicado: (2013)

Clinical significance of androgen secretion disorders in men with a malignancy
por: Wiechno, Pawel J., et al.
Publicado: (2017)

Case report: Androgen-secreting adrenocortical tumors in eight cats
por: Erger, Caylen G., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5s2ha96685ct3jmdth2q0bv1it